Anxiety Disorders and Depression Treatments Market Competitive Market Share, Market by Region, Product & Application, Forecast
The anxiety
and depression are known to be the most common forms of
psychiatric disorders from which a large population is affected
across the globe. . Depression is the most common type of mental
disorder encountered in the global population, while anxiety refers
to the reaction of an individual during stressful situations. Anxiety
disorders are more than normal worry or fear. For a person suffering
from anxiety, the anxious phase of the individual does not get over
and instead worsens over time. This anxious disorder can affect daily
activities such as school work, relationships and job performance.
The anxiety related disorders include generalized anxiety disorder,
social anxiety disorder and panic disorder. Moreover, depression
refers to a common but serious mood disorder. It is related to a
state of emotion that affect thoughts, actions and the sleeping
pattern of an individual. The severity of anxiety and depression
ultimately results into disorders such as phobias, post- traumatic
stress disorder, panic disorder and obsessive compulsive disorder.
Mental illness
encountered at high rates across the globe
The accelerating
prevalence of anxiety and depression are responsible for massive
consumptions of anti- depressants, promoting the growth of the global
anxiety disorders and depression treatments market. According to the
fact sheet of the World Health Organization (WHO) in 2017, over 300
million people of all ages globally are suffering from depression,
wherein 800,000 people die due to suicide, of which, anxiety
disorders and depression are a prime cause. Moreover, according to
the Anxiety and Depression Association of America, anxiety disorders
are reported to be the most common mental illness disease in the
U.S., affecting nearly 18% of the population. The association also
mentions that these disorders are highly treatable thereby propelling
opportunities in the global anxiety disorders and depression
treatment market
The global
anxiety and depression treatment market is segmented on the basis of
class of drug, distribution channel and geography.
On the basis of drug
class, the global anxiety and depression treatment market is
segmented as
SRIs (Selective
Serotonin Reuptake Inhibitors)
SNRIs
(Serotonin-Norepinephrine Reuptake Inhibitors)
TeCAs
(Tetracyclic Antidepressants)
TCAs (Tricyclic
Antidepressants)
MAOIs (Monoamine
Oxidase inhibitors)
Atypical
Antipsychotics
Benzodiazepines
Anticonvulsants
Beta-Blockers
Others
Based on the
distribution channel, the global anxiety and depression treatment
market is segmented as
Pharmacies
E-Commerce
Asia Pacific
expected to exhibit rising anxiety disorders and depression treatment
market due to changing lifestyles
On the basis of
geography, the global anxiety and depression treatment market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East and Africa. North America is the largest market of
anxiety disorder and depression treatment owing to a huge populace
suffering from anxiety, stress related disorders, depression and
also due to the availability and saturation of the U.S.
antidepressants market. According to the Mental Health America, in
2014, 1 in every 5 adults have a mental health condition and the
condition is observed to be worsening at rapid rates in youth.
Additionally, work and life related stress as well as changing
lifestyles in the emerging economies such as India and China are also
potential targets of the global anxiety disorders and depression
treatments market.
Ask For Discount
Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/837
Antidepressants
sales contributing to almost half of the total drug sales across the
globe
The antidepressant
drugs holds almost a share of 50% in the global pharmaceutical
market. Advanced techniques to treat mental illness such as brain
stimulation by using medical implants as well as use of smartphone
based applications like virtual reality exposure therapies, are
helping to boost the global market. However, the side effects of the
antidepressants, adoption of alternative therapies and devices to
treat mental illness are obstructing the growth of the global anxiety
disorder and depression treatment market.
The key players
operating the global anxiety disorders and depression treatments
market are Pfizer Inc., GlaxoSmithKline Plc., H. Lundbeck A/S, Eli
Lily and Company, Inc., Merck and Company, Inc., AstraZeneca Plc,
Forest Laboratories, Sanofi Aventis and Johnson and Johnson. The
companies are indulged in operations such as partnerships, merger and
acquisition as well as research and development partnership in order
to sustain in the competitive market.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment